Single- and Multiple-Dose Pharmacokinetics of an Oral Mixed Amphetamine Salts Extended-Release Formulation in Adults
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Objectives: Assess the bioavailability of mixed amphetamine salts extended-release (MAS XR) 30-mg capsules and the dose proportionality of pharmacokinetic measures for MAS XR 20,40, and 60 mg. Methods: Study A, an open-label single-period study, and Study B, a randomized, open-label, three threeway crossover study, were conducted in healthy adults in a clinical research unit. In Study A, 20 subjects received a single MAS XR 30-mg capsule by mouth daily for 7 days. In Study B, 12 subjects received single oral doses of MAS XR 20,40, and 60 mg separated by 7-14-day washout periods. Findings: Plasma dextroamphetamine (D-amphetamine) and levoamphetamine (L-amphetamine) concentrations were measured using a validated LC-MS/MS method. In Study A, a 3:1 ratio of D-amphetamine to L-amphetamine was observed for AUC 0-∞and C max. T max was 4.2 and 4.3 hours for D-amphetamine to Lamphetamine, respectively. In Study B, for D- and Lamphetamine, statistically significant differences were observed for AUC 0-t, AVC 0-∞, and C max between all doses; there was a linear relationship between pharmacokinetic variables and dose and T max was similar for each isomer (range: 4.5–5.3 hours) with all given MAS XR doses. Conclusion: The extent of exposure as assessed by mean AUC 0-24 and C max reflected the 3:1 ratio of D-amphetamine to L-amphetamine in MAS XR 30-mg capsules. The pharmacokinetic profiles of MAS XR 20, 40, and 60 mg are dose proportional for the isomers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biederman, J. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.816 · Cited by 1,498
Pharmacotherapy of Attention-Deficit Hyperactivity Disorder across the Life Cycle
SPENCER, T., BIEDERMAN, J., WILENS, T., HARDING, M., O'DONNELL, D., & GRIFFIN, S. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199604000-00008 · Cited by 830
Solanto, M. V. (1998) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)00175-7 · Cited by 677
The epidemiology of attention‐deficit/hyperactivity disorder (ADHD): A public health view
Rowland, A. S., Lesesne, C. A., & Abramowitz, A. J. (2002) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.10036 · Cited by 495 · cited 2×
“amphetamine salts extended-release (MAS XR) 30-mg capsules and the dose proportionality of pharmacokinetic measures for MAS XR 20,40, and 60 mg. Methods: Study A, an open-label single-period study, and Study B, a randomized, open-label, three- is a neurobehavioral disorder that is one of the most prevalent chronic hea…”
GREENHILL, L. L., HALPERIN, J. M., & ABIKOFF, H. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199905000-00011 · Cited by 268
Spencer, T., Biederman, J., Wilens, T., Faraone, S., Prince, J., Gerard, K., Doyle, R., Parekh, A., Kagan, J., & Bearman, S. K. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.8.775 · Cited by 250
Analog Classroom Assessment of Adderall® in Children With ADHD
SWANSON, J. M., WIGAL, S., GREENHILL, L. L., BROWNE, R., WASLIK, B., LERNER, M., WILLIAMS, L., FLYNN, D., AGLER, D., CROWLEY, K., et al. (1998) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199805000-00014 · Cited by 218
Preliminary Normative Data on DSM-IV Attention Deficit Hyperactivity Disorder in College Students
Heiligenstein, E., Conyers, L. M., Berns, A. R., & Smith, M. A. (1998) · Journal of American College Health · doi:10.1080/07448489809595609 · Cited by 209
Swanson, J., Kinsbourne, M., Roberts, W., & Zucker, K. (1978) · PEDIATRICS · doi:10.1542/peds.61.1.21 · Cited by 205
Biederman, J., Lopez, F. A., Boellner, S. W., & Chandler, M. C. (2002) · Pediatrics · doi:10.1542/peds.110.2.258 · Cited by 180
Cited by
Weisler, R. H., Biederman, J., Spencer, T. J., Wilens, T. E., Faraone, S. V., Chrisman, A. K., Read, S. C., & Tulloch, S. J. (2006) · CNS Spectrums · doi:10.1017/s1092852900013687 · Cited by 158
“A linear pharmacokinetic profile for MAS XR 20 mg, 40 mg, and 60 mg/day has been demonstrated in healthy adults.(26)This randomized, doubleblind, placebo-controlled, forced-dose-escalation study was designed to assess the efficacy and safety of MAS XR 20, 40, and 60 mg/day in adults with ADHD.”
BackgroundSelf-citationMultiple daily-dose pharmacokinetics of lisdexamfetamine dimesylate in healthy adult volunteers
Krishnan, S. M., & Stark, J. G. (2008) · Current Medical Research and Opinion · doi:10.1185/030079908x242737 · Cited by 55
Attention-Deficit/Hyperactivity Disorder in Adults: Evidence-Based Recommendations for Management
Rostain, A. L. (2008) · Postgraduate Medicine · doi:10.3810/pgm.2008.09.1905 · Cited by 50
Tcheremissine, O. V., & Salazar, J. O. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.8.1299 · Cited by 17
Metadata
- Authors
- Clausen, S. B., Read, S. C., & Tulloch, S. J.
- Venue
- CNS Spectrums
- Publisher
- Cambridge University Press (CUP)
- Published
- 2005-12
- Volume
- 10
- Issue
- S20
- Pages
- 6-15
- ISSN
- 1092-8529 (ISSN-L)
- 2165-6509
- OpenAlex
- W1897329886
- Cited by
- 28
- References
- 17
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Single- and Multiple-Dose Pharmacokinetics of an Oral Mixed Amphetamine Salts Extended-Release Formulation in Adults. https://app.cochat.ai/papers/10.1017/s109285290000239x
- The paper
- Clausen, S. B., Read, S. C., & Tulloch, S. J. (2005). Single- and Multiple-Dose Pharmacokinetics of an Oral Mixed Amphetamine Salts Extended-Release Formulation in Adults. CNS Spectrums. https://doi.org/10.1017/s109285290000239x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.